← All Cardlytics, INC filings

Cardlytics, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
CDLX
Cardlytics, INC
DEF: Cardlytics Annual Meeting: Reverse Stock Split Proposed
Cardlytics announces its 2026 Annual Meeting of Stockholders, proposing a reverse stock split to maintain Nasdaq listing and detailing executive compensation.
NASDAQ
CDLX
Cardlytics, INC
DEFR14A: Cardlytics Files Revised Proxy Statement Due to Omitted Data Tagging
Cardlytics has filed a revised definitive proxy statement to include Inline eXtensible Business Reporting Language data tagging that was initially omitted.
NASDAQ
CDLX
Cardlytics, INC
DEFA14A: Cardlytics, Inc. Files Definitive Proxy Statement
Cardlytics, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
CDLX
Cardlytics, INC
DEF: Cardlytics Sets Date for 2025 Annual Stockholders Meeting, Outlines Key Proposals
Cardlytics has announced its 2025 Annual Meeting of Stockholders to be held on May 20, 2025, outlining proposals including the election of directors, ratification of independent auditors, approval of an equity incentive plan, and an advisory vote on executive compensation.
NASDAQ
CDLX
Cardlytics, INC
DEFA14A: Cardlytics, Inc. Files Definitive Proxy Statement with SEC
Cardlytics, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.
NASDAQ
CDLX
Cardlytics, INC
DEF 14A: Cardlytics Sets Date for 2024 Annual Stockholders Meeting, Board Nominees Announced
Cardlytics will hold its annual stockholders meeting on May 23, 2024, to elect directors, ratify the selection of independent auditors, and approve executive compensation.